Navigation Links
On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
Date:2/19/2008

ne within Compendia and the only practical way to guarantee academic community access to these features was to take full responsibility for website support and data delivery."

"It was a big investment in both time and money, but it has always been critical to us that the academic communities have the same research capabilities as our corporate customers. We are proud that many of these new capabilities are still provided under a free research license," continued John Freshley. "Some advanced custom analyses require a license to Oncomine Research Premium Edition, but this modest investment is a tremendous value given the groundbreaking research that we and others have been able to accomplish using the premium features."

Along with expanded and new customer commitments, Compendia received an additional financial boost in 2007 when awarded a $2.4 million dollar SBIR Fast-Track award from the National Cancer Institute.

"This award was terrific validation of our approach and will allow us to truly scale the Oncomine platform in the future," said Dan Rhodes. "We have already completed the phase I feasibility portion of the award and are looking forward to rapidly executing the rest of the project."

About Compendia Bioscience, Inc.

Compendia Bioscience is dedicated to harnessing the global collection of high throughput molecular data to provide researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical outcomes. http://www.compendiabio.com

About Oncomine(TM)

Oncomine(TM) combines a rapidly growing compendium of 24,000+ cancer transcriptome profiles with a sophisticated analysis engine and a powerful web application for data mining and visualization. Oncomine facilitates rapid and reliable biomarker and therapeutic target discovery, validation, and prioritization
'/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)...  Medelita® has renewed a commitment to identify top ... who have exhibited leadership in their communities and ... year, "The Right Fit H.E.R.O. Honorarium" saw over 200 ... to 10 through a series of criteria, including an ... colleagues in medicine, friends, and family.  In its second ...
(Date:4/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/kz78wm/medical_device ... "Medical Device Studies: Clinical Evidence" conference to ... designed specifically for those who are involved in ... in-vitro diagnostic products. Clinical data is required for ... quality, appropriate clinical evidence has grown substantially in ...
(Date:4/1/2015)... April 1, 2015  Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... offering of $60.0 million aggregate principal amount of ... in a private placement to qualified institutional buyers ... of 1933, as amended (the "Act"). Egalet also ...
Breaking Medicine Technology:Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4Medical Device Studies: Clinical Evidence Seminar - London, UK, 13th, 14th of May 2015 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7
... Informa business unit, and the world,s leading research authority ... the 14th International Conference on Alzheimer,s Disease (ICAD 2011/AAIC ... to develop beta amyloid targeting drugs, amyloid targets are ... for risk of Alzheimer,s. According to Dr. ...
... ShangPharma Corporation (NYSE: SHP ) ("ShangPharma" or ... and development outsourcing company, today announced that it has ... its biologics division, which portends strong growth for this ... were achieved for two oncology projects that are under ...
Cached Medicine Technology:Global Standardization for Alzheimer's Biomarkers Moves a Major Step Closer to Reality 2ShangPharma's Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects 2
(Date:4/1/2015)... 01, 2015 Alcohol Awareness Month , ... (NCADD) has been sponsoring Alcohol Awareness Month every April ... awareness and increase understating of alcohol-related issues. During ... on alcohol-related issues, and alcoholism. , For the Health ... the 2015 theme for Alcohol Awareness Month. During ...
(Date:4/1/2015)... 01, 2015 NTOCC today launches the ... care tools that seek to improve care transitions and ... NTOCC hopes to bring light to tools or resources ... care across the healthcare industry through the promotion of ... collaborative patient-care. Following that vision, the Knowledge & Resource ...
(Date:4/1/2015)... 2015 New Jersey Governor First ... First Spouses from across the country in sponsoring ... 2015, World Down Syndrome Day(WDSD), to increase awareness ... area of Down syndrome cognition research. , In ... Alaska, American Samoa, Arizona, California, Colorado, Delaware, Florida, ...
(Date:4/1/2015)... Springs, FL (PRWEB) April 01, 2015 ... nation’s leading innovative specialty pharmacies, has released a new ... latest treatment guidelines for treating chronic hepatitis C virus ... treatment guidelines based on information from the American Association ... credible, scientific sources. , Numerous new direct-acting oral medications ...
(Date:4/1/2015)... Vancouver, BC (PRWEB) April 01, 2015 ... recently announced that she is now offering her patients ... and services. Patients can participate in “Beauty Days”, which ... year by Dr Roz Kamani’s Kitsilano Skin Care Clinic. ... will directly tell patients about the latest products and ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 2Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 3Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2
... ROCKVILLE, Md., Jan. 9 The perception that,U.S. doctors ... to,prevent them is untrue, according to a new study ... Because most doctors think that current systems to ... instead on informal,discussions with their colleagues. Consequently, important information,about ...
... Those who suffer from allergic,asthma, rhinitis, conjunctivitis or ... immunotherapy, also known as "allergy shots,",according to the ... "Immunotherapy is a form of treatment that ... Linda Cox, MD, FAAAAI, Chair of the,AAAAI,s Immunotherapy ...
... menopause drugs are unregulated and could be dangerous, ... -- U.S. health officials warned Wednesday about so ... increasing popular alternative therapy among women with menopausal ... officials said they,ve sent warning letters to seven ...
... Not to Compound Commonly Prescribed Hormone,Treatments, Use the ... In a series of,warning letters to compounding ... (FDA) has asserted a policy that would deny ... bioidentical hormones,commonly, substituting its judgment for that of ...
... CHAPEL HILL, N.C., Jan. 9 Companies competing ... and bureaucratic,standards. Organizations have come to rely on ... requirements. But effective quality systems,don,t just spontaneously spring ... key to creating and maintaining a quality operation ...
... Fla., Jan. 9 Liberator Medical,Supply, Inc. (OTC ... Holdings, Inc., announced today that it has exceeded,management,s ... a new,company record for the highest monthly and ... is approaching the break-even point and that,we anticipate ...
Cached Medicine News:Health News:Physicians Want to Learn From Medical Mistakes But Say Current Error-Reporting Systems are Inadequate 2Health News:Physicians Want to Learn From Medical Mistakes But Say Current Error-Reporting Systems are Inadequate 3Health News:A Few Shots Away: Immunotherapy May Relieve Allergy Symptoms 2Health News:A Few Shots Away: Immunotherapy May Relieve Allergy Symptoms 3Health News:FDA Warns Against Bio-Identical Hormone Therapy 2Health News:FDA Warns Against Bio-Identical Hormone Therapy 3Health News:FDA Asserts New Policy to Restrict Women's Access to Bioidentical Hormones 2Health News:Integrating Quality into Business Systems for High Performance, Complimentary Excerpt Available from Best Practices, LLC 2Health News:Liberator Medical Holdings Exceeds December Sales 2
Enzyme Immunoassay of Tissue Plasminogen Activator Antigen by ELISA Method, 96 tests....
Citrated human plasma for the calibration of vWF assays by the immuno-turbidimetric method on STA© analyzers.(STA© Liatest© vWF #0518)....
Heparin-Platelet Factor 4 Induced Antibody...
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
Medicine Products: